Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism

Journal of Virology

Volumn 88, Issue 15, 2014, Pages 8556-8564

  Spence, Jennifer S ^a   Melnik, Lilia I ^a   Badani, Hussain ^a   Wimley, William C ^a   Garry, Robert F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AVP P; GLYCOPROTEIN; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARENAVIRUS INFECTION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENCY; ENDOCYTOSIS; IC 50; IN VITRO STUDY; NONHUMAN; PICHINDE ARENAVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN INTERACTION; VIRION; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS PLAQUE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CRYOELECTRON MICROSCOPY; GLYCOPROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PICHINDE VIRUS; VIRAL PLAQUE ASSAY; VIRION; VIRUS INTERNALIZATION;

EID: 84903885404     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01133-14     Document Type: Article

References (31)

1. NIAID. 2002. NIAID biodefense research agenda for CDC category A agents. NIH publication no. 03-5308. NIH, Bethesda, MD.
2. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
3. Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, Pinneo L, Gary GW, Kissling RE. 1973. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am. J. Trop. Med. Hyg. 22:773-779.
4. Fisher-Hoch SP, Tomori O, Nasidi A, Perez-Oronoz GI, Fakile Y, Hutwagner L, McCormick JB. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311:857-859. http://dx.doi.org/10.1136/bmj.311.7009.857.
5. Peters CJ. 2002. Human infection with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol. 262:65-74.
6. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
7. Russmann S, Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. 2006. Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr. Med. Chem. 13:3351-3357. http://dx.doi.org/10.2174/092986706778773059.
8. Eschli B, Quirin K, Wepf A, Weber J, Zinkernagel RM, Hengartner H. 2006. Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I fusion proteins. J. Virol. 80:5897-5907. http://dx.doi.org/10.1128/JVI.00008-06.
9. Igonet S, Vaney MC, Vonhrein C, Bricogne G, Stura EA, Hengartner H, Eschli B, Rey FA. 2011. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc. Natl. Acad. Sci. U.S.A. 108:19967-19972. http://dx.doi.org/10.1073/pnas.1108910108.
10. Muñoz-Barroso I, Durell S, Sakaguchi K, Appella E, Blumenthal R. 1998. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140:315-323. http://dx.doi.org/10.1083/jcb.140.2.315.
11. Sainz B, Jr, Mossel EC, Gallaher WR, Peters CJ, Wilson RB, Garry RF. 2006. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Virus Res. 120:146-155. http://dx.doi.org/10.1016/j.virusres.2006.03.001.
12. Lee KK, Pessi A, Gui L, Santoprete A, Talekar A, Moscona A, Porotto M. 2011. Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus. J. Biol. Chem. 286:42141-42149. http://dx.doi.org/10.1074/jbc.M111.254243.
13. Rapaport D, Ovadia M, Shai Y. 1995. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai viruscell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:5524-5531.
14. Watanabe S, Takada A, Watanabe T, Ito H, Kida H, Kawaoka Y. 2000. Functional importance of the coiled-coil of the Ebola virus glycoprotein. J. Virol. 74:10194-10201. http://dx.doi.org/10.1128/JVI.74.21.10194-10201.2000.
15. Neuman BW, Adair BD, Yeager M, Buchmeier MJ. 2008. Purification and electron microscopy of coronavirus particles. Methods Mol. Biol. 454: 129-136. http://dx.doi.org/10.1007/978-1-59745-181-9_12.
16. Hoekstra D, de Boer T, Klappe K, Wilschut J. 1984. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675-5681. http://dx.doi.org/10.1021/bi00319a002.
17. Di Simone C, Zandonatti MA, Buchmeier MJ. 1994. Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike. Virology 198:455-465. http://dx.doi.org/10.1006/viro.1994.1057.
18. Neuman BW, Adair BD, Burns JW, Milligan RA, Buchmeier MJ, Yeager M. 2005. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79:3822-3830. http://dx.doi.org/10.1128/JVI.79.6.3822-3830.2005.
19. Wimley WC, White SH. 1996. Experimentally determined hydrophobic-ity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3:842-848. http://dx.doi.org/10.1038/nsb1096-842.
20. Hrobowski YM, Garry RF, Michael SF. 2005. Peptide inhibitors of dengue virus and West Nile Virus infectivity. Virol. J. 2:49. http://dx.doi.org/10.1186/1743-422X-2-49.
21. Melnik LI, Garry RF, Morris CA. 2011. Peptide inhibition of human cytomegalovirus infection. Virol. J. 8:76. http://dx.doi.org/10.1186/1743-422X-8-76.
22. Blumenthal R, Sarkar DP, Durell S, Howard DE, Morris SJ. 1996. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion. J. Cell Biol. 135:63-71. http://dx.doi.org/10.1083/jcb.135.1.63.
23. Danieli T, Pelletier SL, Henis YI, White JM. 1996. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:559-569. http://dx.doi.org/10.1083/jcb.133.3.559.
24. Roche S, Gaudin Y. 2002. Characterization of the equilibrium between the native and fusion-inactive conformation of the rabies virus glycoprotein indicates that the fusion complex is made of several trimers. Virology 297:128-135. http://dx.doi.org/10.1006/viro.2002.1429.
25. Leikina E, Mittal A, Cho MS, Melikov K, Kozlov MM, Chernomordik LV. 2004. Influenza hemagglutinins outside of the contact zone are necessary for fusion pore expansion. J. Biol. Chem. 279:26526-26532. http://dx.doi.org/10.1074/jbc.M401883200.
26. Agnihothram SS, York J, Trahey M, Nunberg JH. 2007. Bitopic membrane topology of the stable signal peptide in the tripartite Junin virus GP-C envelope glycoprotein complex. J. Virol. 81:4331-4337. http://dx.doi.org/10.1128/JVI.02779-06.
27. Messina EL, York J, Nunberg JH. 2012. Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion. J. Virol. 86:6138-6145. http://dx.doi.org/10.1128/JVI.07241-11.
28. York J, Nunberg JH. 2006. Role of the stable signal peptide of the Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J. Virol. 80:7775-7780. http://dx.doi.org/10.1128/JVI.00642-06.
29. York J, Nunberg JH. 2009. Intersubunit interactions modulate the pH-induced activation of membrane fusion by the Junin virus envelope glycoprotein GPC. J. Virol. 83:4121-4126. http://dx.doi.org/10.1128/JVI.02410-08.
30. Porotto M, Yi F, Moscona A, LaVan DA. 2011. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS One 6:e16874. http://dx.doi.org/10.1371/journal.pone.0016874.
31. Farzan SF, Palermo LM, Yokoyama CC, Orefice G, Fornabaio M, Sakar A, Kellogg GE, Greengard O, Porotto M, Moscona A. 2011. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery. J. Biol. Chem. 286: 37945-37954. http://dx.doi.org/10.1074/jbc.M111.256248.